Evidence map›Paper›PMID 26856840›Full record

ArticleAntimicrobial agents and chemotherapy2016

Antimicrobial Resistance in Salmonella in the United States from 1948 to 1995.

Daniel A Tadesse, Aparna Singh, Shaohua Zhao, Mary Bartholomew, Niketta Womack, Sherry Ayers, Patricia I Fields, Patrick F McDermott

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Veterinary sciences · 2024
    Review
  3. A Retrospective Analysis ofMicroorganisms · 2024
    Article
  4. Whole-Genome Sequencing Analysis of Non-TyphoidalAntibiotics (Basel, Switzerland) · 2023
    Article
  5. Antimicrobial agents and chemotherapy · 2022
    Article
  6. Article
  7. Review
  8. Prevalence, Antimicrobial Resistance, and Diversity ofPathogens (Basel, Switzerland) · 2019
    Article
  9. Article
  10. Antimicrobial Resistance in NontyphoidalMicrobiology spectrum · 2018
    Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Daniel A TadesseU.S. Food and Drug Administration, Center for Veterinary Medicine, U.S. Department of Health and Human Services, Laurel, Maryland, USA.
Aparna SinghNational Institutes of Health, U.S. Department of Health and Human Services, Bethesda, Maryland, USA.
Shaohua ZhaoU.S. Food and Drug Administration, Center for Veterinary Medicine, U.S. Department of Health and Human Services, Laurel, Maryland, USA.
Mary BartholomewU.S. Food and Drug Administration, Center for Veterinary Medicine, U.S. Department of Health and Human Services, Rockville, Maryland, USA.
Niketta WomackU.S. Food and Drug Administration, Center for Veterinary Medicine, U.S. Department of Health and Human Services, Laurel, Maryland, USA.
Sherry AyersU.S. Food and Drug Administration, Center for Veterinary Medicine, U.S. Department of Health and Human Services, Laurel, Maryland, USA.
Patricia I FieldsCenters for Disease Control and Prevention, Division of Foodborne, Waterborne, and Environmental Diseases, U.S. Department of Health and Human Services, Atlanta, Georgia, USA.
Patrick F McDermottU.S. Food and Drug Administration, Center for Veterinary Medicine, U.S. Department of Health and Human Services, Laurel, Maryland, USA patrick.mcdermott@fda.hhs.gov.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We conducted a retrospective study of 2,149 clinicalSalmonellastrains to help document the historical emergence of antimicrobial resistance. There were significant increases in resistance to older drugs, including ampicillin, chloramphenicol, streptomycin, sulfamethoxazole, and tetracycline, which were most common inSalmonella entericaserotype Typhimurium. An increase in multidrug resistance was observed for each decade since the 1950s. These data help show howSalmonellaevolved over the past 6 decades, after the introduction of new antimicrobial agents.

Indexed as

AmpicillinAnti-Bacterial AgentsChloramphenicolDrug Resistance, Multiple, BacterialEvolution, MolecularHumansMicrobial Sensitivity TestsPhenotypePublic Health SurveillanceSalmonella InfectionsSalmonella typhimuriumSerogroupStreptomycinSulfamethoxazoleTetracyclineUnited StatesAmpicillinAnti-Bacterial AgentsChloramphenicolStreptomycinSulfamethoxazoleTetracycline

Identifiers

PMID26856840
PMCPMC4808194

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.